SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-284927
Filing Date
2015-08-10
Accepted
2015-08-10 16:28:19
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d96443d10q.htm 10-Q 341270
2 EX-10.1 d96443dex101.htm EX-10.1 11042
3 EX-31.1 d96443dex311.htm EX-31.1 8558
4 EX-31.2 d96443dex312.htm EX-31.2 8571
5 EX-32.1 d96443dex321.htm EX-32.1 4903
  Complete submission text file 0001193125-15-284927.txt   2709696

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT omed-20150630.xml EX-101.INS 465237
7 XBRL TAXONOMY EXTENSION SCHEMA omed-20150630.xsd EX-101.SCH 34980
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE omed-20150630_cal.xml EX-101.CAL 46451
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE omed-20150630_def.xml EX-101.DEF 131695
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE omed-20150630_lab.xml EX-101.LAB 280820
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omed-20150630_pre.xml EX-101.PRE 223105
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Filer) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35993 | Film No.: 151041097
SIC: 2834 Pharmaceutical Preparations